Patients and treatments characteristics
| N. (%) | |
|---|---|
| Patients | 84 |
| Lesions | 126 |
|
Age, yrs
Median (range) | 58 (30-92) |
|
ECOG Performance Status
0-1 2-3 | 79 (94.1) 5 (5.9) |
|
Histotype
Squamous Adenocarcinoma Adenosquamous Clear cell Other | 77 (61.1) 36 (28.6) 5 (4.0) 3 (2.4) 5 (4.0) |
|
N. lesions per patients
1 2 >3 | 61 (72.6) 13 (15.4) 10 (12.0) |
|
Type of lesion (%)
Lymph node Parenchyma Bone | 70 (55.5) 46 (36.5) 10 (8.0) |
|
Anatomic Site
Neck Thorax Abdomen Pelvis Bone | 7 (5.5) 34 (27.0) 32 (25.4) 46 (36.6) 7 (5.5) |
|
Metachronous lesions
No Yes | 99 (78.6) 27 (21.4) |
|
N. patients undergoing previous radiotherapy in site
No Yes | 53 (63.1) 31 (36.9) |
|
Equipments
INAC Cyberknife Tomotherapy MRI LINAC | 108 (85.7) 10 (7.9) 1 (0.8) 7 (5.6) |
|
Type of treatment
SRS, stereotactic radiosurgery (single fraction) SBRT, stereotactic radiotherapy (more fractions) | 26 (20.6) 100 (79.4) |
|
PTV
Median, range (cc) | 16.8 (1.8-223.3) |
|
Total dose, Gy
Median (range) | 35 (5-60) |
|
Dose/fraction, Gy
Median (range) | 7 (2.5-26) |
|
Dose prescription
Specific isodose Isocenter Target mean | 48 (38.1) 32 (25.4) 46 (36.5) |